• 1
    Raithel M, Matek M, Baenkler HW, et al. Mucosal histamine content and histamine secretion in Crohn's disease, ulcerative colitis and allergic enteropathy. Int Arch Allergy Immunol 1995; 108: 12733.
  • 2
    Oshitani N, Campbell A, Kitano A, et al. In situ comparison of phenotypical and functional activity of infiltrating cells in ulcerative colitis mucosa. J Pathol 1996; 178: 9599.
  • 3
    Xiang XU, Weksler-Zangen S, Pikarsky A, et al. Mast cells involvement in the inflammation and fibrosis development of the TNBS-induced rat model of colitis. Scand J Gastroenterol 2002; 37: 33037.
  • 4
    Sakakibara A, Baka K, Niwa S, et al. Kinetic study on airway mast cells in bronchial mucosa obtained from patients suffering from chronic cough by double staining with a newly developed antibody. J Aichi Med Univ Assoc 2002; 30: 113.
  • 5
    Matts SGF. The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med 1961; 30: 393407.
  • 6
    Enerbäck L. Mast cells in rat gastrointestinal mucosa. I. Effects of fixation. Acta Pathol Microbiol Scand 1966; 66: 289302.
  • 7
    Wingren U, Enerbäck L. Mucosal mast cells of the rat intestine: a re-evaluation of fixation and staining properties, with special reference to protein blocking and solubility of the granular glycosaminoglycan. Histochem J 1983; 15: 57182.
  • 8
    Stenton GR, Vliagoftis H, Befus D. Role of intestinal mast cells in modulating gastrointestinal pathophysiology. Ann Allergy Asthma Immunol 1998; 81: 115.
  • 9
    Scott RB, Diamant SC, Gall DG. Motility effects of intestinal anaphylaxis in the rat. Am J Physiol 1988; 255: G50511.
  • 10
    Diamant SC, Gall DG, Scott RB. The effect of intestinal anaphylaxis on postprandial motility in the rat. Can J Physiol Pharmacol 1989; 67: 132630.
  • 11
    Burakoff R, Nastos E, Won S, et al. Comparison of the effects of leukotrienes B4 and D4 on distal colonic motility in the rabbit in vivo. Am J Physiol 1989; 257: G8604.
  • 12
    Bissonnette EY, Hogaboam CM, Wallace JL, et al. Potentiation of tumor necrosis factor-alpha-mediated cytotoxicity of mast cells by their production of nitric oxide. J Immunol 1991; 147: 30605.
  • 13
    Bischoff SC, Wedemeyer J, Herrmann A, et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 1996; 28: 113.
  • 14
    Dunlop SP, Jenkins D, Spiller RC. Age-related decline in rectal mucosal lymphocytes and mast cells. Eur J Gastroenterol Hepatol 2004; 16: 10115.
  • 15
    Galli SJ, Tsai M, Wershil BK. The c-kit receptor, stem cell factor, and mast cells: what each is teaching us about the other. Am J Pathol 1993; 142: 96574.
  • 16
    Grabbe J, Ewlker P, Dippel B, et al. Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch Dermatol Res 1994; 287: 7884.
  • 17
    Huttunen M, Naukkarinen A, Horsmanheimo M, et al. Transient production of stem cell factor in dermal cells but increasing expression of Kit receptor in mast cells during normal wound healing. Arch Dermatol Res 2002; 294: 32430.
  • 18
    Hamann K, Grabbe J, Welker P, et al. Phenotypic evaluation of cultured human mast and basophilic cells and of normal human skin mast cells. Arch Dermatol Res 1994; 286: 3805.
  • 19
    Ghannadan M, Baghestanian M, Wimazal F, et al. Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies. J Invest Dermatol 1998; 111: 68995.
  • 20
    Xu X, Rivkind A, Pikarsky A, et al. Mast cells and eosinophils have a potential profibrogenic role in Crohn Disease. Scand J Gastroenterol 2004; 39: 44047.